Syndax Pharmaceuticals Inc (SNDX)
18.94
-0.04
(-0.21%)
USD |
NASDAQ |
Nov 04, 16:00
18.50
-0.44
(-2.32%)
After-Hours: 20:00
Syndax Pharmaceuticals Price to Book Value: 3.711 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 3.711 |
| November 01, 2024 | 3.719 |
| October 31, 2024 | 3.695 |
| October 30, 2024 | 3.707 |
| October 29, 2024 | 3.738 |
| October 28, 2024 | 3.764 |
| October 25, 2024 | 3.674 |
| October 24, 2024 | 3.721 |
| October 23, 2024 | 3.632 |
| October 22, 2024 | 3.754 |
| October 21, 2024 | 3.826 |
| October 18, 2024 | 3.862 |
| October 17, 2024 | 3.897 |
| October 16, 2024 | 3.897 |
| October 15, 2024 | 3.870 |
| October 14, 2024 | 3.883 |
| October 11, 2024 | 3.748 |
| October 10, 2024 | 3.566 |
| October 09, 2024 | 3.589 |
| October 08, 2024 | 3.601 |
| October 07, 2024 | 3.578 |
| October 04, 2024 | 3.687 |
| October 03, 2024 | 3.662 |
| October 02, 2024 | 3.809 |
| October 01, 2024 | 3.897 |
| Date | Value |
|---|---|
| September 30, 2024 | 3.772 |
| September 27, 2024 | 3.701 |
| September 26, 2024 | 3.558 |
| September 25, 2024 | 3.530 |
| September 24, 2024 | 3.582 |
| September 23, 2024 | 3.513 |
| September 20, 2024 | 3.580 |
| September 19, 2024 | 3.65 |
| September 18, 2024 | 3.527 |
| September 17, 2024 | 3.538 |
| September 16, 2024 | 3.566 |
| September 13, 2024 | 3.746 |
| September 12, 2024 | 3.525 |
| September 11, 2024 | 3.589 |
| September 10, 2024 | 3.685 |
| September 09, 2024 | 3.683 |
| September 06, 2024 | 3.742 |
| September 05, 2024 | 3.840 |
| September 04, 2024 | 3.850 |
| September 03, 2024 | 4.024 |
| August 30, 2024 | 4.026 |
| August 29, 2024 | 3.960 |
| August 28, 2024 | 4.048 |
| August 27, 2024 | 4.077 |
| August 26, 2024 | 4.101 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.998
Minimum
Feb 14 2022
14.15
Maximum
May 15 2020
4.341
Average
3.795
Median
Price to Book Value Benchmarks
| Incyte Corp | 4.602 |
| Trevena Inc | -- |
| Bristol-Myers Squibb Co | 6.561 |
| Arcus Biosciences Inc | 2.240 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PEG Ratio | -0.1433 |
| Price | 18.94 |
| Earnings Yield | -17.85% |
| Market Cap | 1.612B |
| PEGY Ratio | -0.1433 |